Early‐onset pneumonia after liver transplantation: Microbiological findings and therapeutic consequences
Emmanuel Weiss, Souhayl Dahmani, Frederic Bert, Sylvie Janny, Daniel Sommacale, Federica Dondero, Claire Francoz, Jacques Belghiti, Jean Mantz, Catherine Paugam‐Burtz – 16 July 2010 – Early‐onset hospital‐acquired pneumonia (E‐HAP) is one of the leading causes of sepsis and mortality after liver transplantation (LT). The appropriate antimicrobial therapy is crucially important for surviving sepsis in this context. The aim of this study was to analyze microbiological findings, associated factors, and optimal antibiotic regimens for E‐HAP after LT.